Tysabri Maybe Not So Great for Crohn's Disease
Filed Under Multiple Sclerosis General |
Bloomberg ran an article here Tysabri May Have Limited Benefit in Crohn’s, FDA Says (Update5) that says Tysabri might not be as effective for Crohn’s disease as previously thought.
Although Tysabri has been shown to be approximately twice as effective in the treatment of multiple sclerosis as other drugs, it seems that Tysabri hasn’t clearly distinguished itself as being any better than existing Crohn’s drugs.
I’m sure that this is sad news for sufferers of Crohn’s disease as I know that they were hoping for much better results from Tysabri. Apparently, investors felt disappointed also, since Biogen’s shares fell approximately 2 percent on the NASDAQ, down $1.18 to $57.01. By contrast, the stock has risen a total of 16 percent this year.
- Vince
Comments
Leave a Reply